- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01209169
Evaluation of Novel Biomarkers From Acutely Ill Patients at Risk for Acute Kidney Injury
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Innsbruck, Austria, 6020
- University Clinic for Internal Medicine
-
-
-
-
Alberta
-
Edmonton, Alberta, Canada, T6G 2B7
- University of Alberta
-
-
-
-
-
Lyon, France, 69003
- Edouard Herriot Hospital
-
Melun, France, 77000
- Marc Jacquet Hospital
-
Pessac, France, 33600
- Haut-Lévêque Hospital
-
-
-
-
-
Aachen, Germany, 52074
- Universitätsklinikum Aachen
-
Frankfurt, Germany, 60590
- Klinik für Anästhesie, Intensivmedizin und Schmerztherapie
-
Frankfurt, Germany, 60590
- Universitätsklinik Frankfurt am Main
-
Madgeburg, Germany, 39120
- Otto-von-Guericke-Universitat Magdeburg
-
-
Belgium
-
Brussel, Belgium, Germany, 1090
- UZ Brussel
-
Ghent, Belgium, Germany, 9000
- Ghent University Hospital
-
-
-
-
-
Sabadell, Spain, 08208
- Critical Care Center, Sabadell Hospital
-
-
-
-
Stockholm
-
Solna, Stockholm, Sweden, 17176
- Karolinska University Hospital
-
-
-
-
England
-
London, England, United Kingdom, SE5 9RS
- King's College Hospital
-
London, England, United Kingdom, SE1 7EH
- Guy's and St. Thomas Hospital
-
-
West Sussex
-
Worthing, West Sussex, United Kingdom, BN11 2DH
- Worthing Hospital
-
-
-
-
Arizona
-
Phoenix, Arizona, United States, 85008
- Maricopa Intergrated Health System
-
-
California
-
San Diego, California, United States, 92103-8781
- University of California San Diego
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20037
- George Washington University
-
-
Florida
-
Gainesville, Florida, United States, 32610-0254
- University of Florida
-
Miami, Florida, United States, 33125
- Bruce W. Carter Department of Veterans Affairs Medical Center
-
Tampa, Florida, United States, 33606
- Tampa General Hospital
-
-
Georgia
-
Augusta, Georgia, United States, 30909
- Joseph M. Still Research Foundation, Inc.
-
-
Illinois
-
Chicago, Illinois, United States, 60637
- University of Chicago Medical Center Section of Nephrology
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- University of Maryland Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth Israel Deaconess Med. Center (BIDMC)
-
-
Michigan
-
Novi, Michigan, United States, 48374
- Providence Park Hospital
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center
-
Brooklyn, New York, United States, 11215
- New York Methodist Hospital
-
-
North Carolina
-
Durham, North Carolina, United States, 27705
- Durham VA Medical Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15261
- University of Pittsburgh Medical Center
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Males and females 21 years of age or older;
Subjects enrolled (first sample collection) from ED or Floor admitted to the ICU within 24 hours of enrollment; Subjects enrolled from ICU admitted to the ICU within the 24 hours prior to enrollment; Expected to remain in the ICU for at least 48 hours after enrollment; Use of indwelling urinary catheter as standard care expected for at least 48 hours after enrollment; At least one of the following acute conditions within 24 hours prior to enrollment:
(Respiratory SOFA score of ≥ 2 (PaO2/FiO2 <300)and/or Cardiovascular SOFA score of ≥ 1 (MAP < 70 mm Hg and/or any vasopressor required).
Patient (or authorized representative) able and willing to provide written informed consent for study participation.
Exclusion Criteria:
Special populations including women with known pregnancy, prisoners or institutionalized individuals;Previous renal transplantation;Known acutely worsening renal function prior to enrollment (e.g., any category of RIFLE criteria. Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment; Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic);Patient meets any of the following:Active bleeding with an anticipated need for > 4 units PRBC;Hemoglobin < 7 g/dL;Any other condition that in the physician's opinion would contraindicate drawing serial blood samples for clinical study purposes.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Evaluation of Novel Biomarkers From Acutely ill Patients at Risk for AKI.
Time Frame: 10/2010 to 2/2013
|
Primary outcome measure: Identification and Validation of Biomarkers from Acutely ill patients at risk for AKI.
(N=744) Secondary outcomes including follow-up (N=890).
|
10/2010 to 2/2013
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: John Kellum, MD, Professor, Critical Care Medicine, University of Pittsburgh
Publications and helpful links
General Publications
- Hoste EA, McCullough PA, Kashani K, Chawla LS, Joannidis M, Shaw AD, Feldkamp T, Uettwiller-Geiger DL, McCarthy P, Shi J, Walker MG, Kellum JA; Sapphire Investigators. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014 Nov;29(11):2054-61. doi: 10.1093/ndt/gfu292. Epub 2014 Sep 18.
- Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmele T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013 Feb 6;17(1):R25. doi: 10.1186/cc12503.
- Kellum JA, Artigas A, Gunnerson KJ, Honore PM, Kampf JP, Kwan T, McPherson P, Nguyen HB, Rimmele T, Shapiro NI, Shi J, Vincent JL, Chawla LS; Sapphire Investigators. Use of Biomarkers to Identify Acute Kidney Injury to Help Detect Sepsis in Patients With Infection. Crit Care Med. 2021 Apr 1;49(4):e360-e368. doi: 10.1097/CCM.0000000000004845.
- McCullough PA, Ostermann M, Forni LG, Bihorac A, Koyner JL, Chawla LS, Shi J, Kampf JP, McPherson P, Kellum JA; the Sapphire Investigators. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness. Cardiorenal Med. 2019;9(6):358-369. doi: 10.1159/000502837. Epub 2019 Oct 16.
- Kane-Gill SL, Ostermann M, Shi J, Joyce EL, Kellum JA. Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin-Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study. Drug Saf. 2019 Oct;42(10):1149-1155. doi: 10.1007/s40264-019-00846-x.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAPPHIRE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Kidney Injury
-
Instituto Nacional de Cardiologia Ignacio ChavezInstituto Nacional de Ciencias Medicas y Nutricion Salvador ZubiranUnknownKidney Injury, Acute | Acute Renal Injury | Acute Kidney Injuries | Kidney Injuries, Acute | Acute Renal InjuriesMexico
-
Yonsei UniversityCompletedAcute Kidney Injury(Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery)Korea, Republic of
-
University Hospital, GhentWithdrawn
-
Beni-Suef UniversityCairo UniversityRecruitingAKI - Acute Kidney InjuryEgypt
-
University Hospital MuensterBaxter Healthcare CorporationCompletedAcute Kidney Injury (AKI)Spain, France, United States, Turkey, Germany, Egypt, Italy, Libyan Arab Jamahiriya, Malta, North Macedonia, Palestinian Territory, occupied, Russian Federation, Saudi Arabia, Slovenia
-
Chinese PLA General HospitalBeijing Tsinghua Changgeng HospitalCompletedPostoperative Acute Kidney InjuryChina
-
Chinese PLA General HospitalCompletedPostoperative Acute Kidney InjuryChina
-
Ain Shams UniversityRecruiting
-
Astellas Pharma IncCompleted
-
South Egypt Cancer InstituteCompletedAcute Kidney Injury (AKI)Egypt